Simple Summary Mitochondria, often called “the powerhouse of the cell”, generate most of
the energy required for all cellular processes. Mitochondria also provide a platform for …

Triple-negative breast cancer (TNBC) is usually the most malignant and aggressive
mammary epithelial tumor characterized by the lack of expression for estrogen receptors …

Cancer stem-like cells (CSCs) contribute to cancer metastasis, drug resistance and tumor
relapse, yet how amino acid metabolism promotes CSC maintenance remains exclusive …

Triple-negative breast cancer (TNBC) metabolism and cell growth uniquely rely on
glutamine uptake by the transporter ASCT2. Despite previous data reporting cell growth …

Certain aggressive cancers, such as triple-negative breast cancer (TNBC), heavily bank on
glutamine for their proliferation and survival. In this context, TNBC functions as a “glutamine …

PoRVA and PEDV coinfections are extremely common in clinical practice. Although
coinfections of PoRVA and PEDV are known to result in increased mortality, the underlying …

We present the use of conductive spray polymer ionization mass spectrometry (CPSI-MS)
combined with machine learning (ML) to rapidly gain the metabolic fingerprint from 1 μl …

Molecular characterization is transforming research on novel therapeutics in breast cancer.
High-throughput methodologies are unbiased to hypotheses; thus, data produced are …

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) is a member of a family of
peptidyl-prolyl isomerases that specifically recognizes and binds phosphoproteins …

Cisplatin (cDDP) resistance is a matter of concern in triple-negative breast cancer
therapeutics. We measured the metabolic response of cDDP-sensitive (S) and-resistant (R) …